机构

• 化学研究所 [16]
• 上海药物研究所 [15]

采集方式

• OAI收割 [31]

内容类型

• 期刊论文 [31]

发表日期

• 2023 [2]
• 2022 [1]
• 2021 [1]
• 2020 [1]
• 2019 [3]
• 2015 [2]
• 更多

学科主题

筛选

浏览/检索结果: 共31条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序题名升序题名降序作者升序作者降序发表日期升序发表日期降序 SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer 期刊论文  OAI收割 SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 卷号: 8, 期号: 1, 页码: 13 作者:  Zhou, Ji;  Zhang, Xu-Chao;  Xue, Shan;  Dai, Mengdi;  Wang, Yueliang   |  收藏  |  浏览/下载：12/0  |  提交时间：2023/10/17 Fine-tuning Bacterial Cyclic di-AMP Production for Durable Antitumor Effects Through the Activation of the STING Pathway 期刊论文  OAI收割 RESEARCH, 2023, 卷号: 6, 页码: 15 作者:  Jiang, Yu;  Li, Xiyuan;  Qian, Fenghui;  Sun, Bingbing;  Wang, Xiyuan   |  收藏  |  浏览/下载：26/0  |  提交时间：2023/10/17 Novel Sphingosine Kinase 1 Inhibitor Suppresses Growth of Solid Tumor and Inhibits the Lung Metastasis of Triple-Negative Breast Cancer 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 65, 期号: 11, 页码: 7697-7716 作者:  Zhang, Shurui;  Chen, Xiaoxu;  Wu, Chenglin;  Xu, Hui;  Xie, Xiong   |  收藏  |  浏览/下载：18/0  |  提交时间：2022/08/16 Discovery of novel ceramide analogs with favorable pharmacokinetic properties and combination with AKT inhibitor against colon cancer 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 215, 页码: 13 作者:  Gao, Feng;  Chen, Xiaoxu;  Lu, Junyan;  Hu, Shulei;  Xu, Hui   |  收藏  |  浏览/下载：20/0  |  提交时间：2021/05/24 Ceramide analogs  AKT inhibitor  MK2206  Colon cancer  Combination therapy   Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models. 期刊论文  OAI收割 CANCER IMMUNOLOGY RESEARCH, 2020, 卷号: 8, 期号: 3, 页码: 70-70 作者:  Dai, Yang;  Ji, Yichun;  Shen, Yanyan;  Su, Yi;  Liu, Bo   |  收藏  |  浏览/下载：40/0  |  提交时间：2020/07/01 Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models 期刊论文  OAI收割 JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 卷号: 38, 期号: 1, 页码: 16 作者:  Peng, Xia;  Hou, Pengcong;  Chen, Yi;  Dai, Yang;  Ji, Yinchun   |  收藏  |  浏览/下载：23/0  |  提交时间：2020/07/01 Kinase inhibitor  FGFR  CSF-1R  Tumor microenvironment   Prognostic value of ephrin B receptors in breast cancer: An online survival analysis using the microarray data of 3,554 patients 期刊论文  OAI收割 ONCOLOGY LETTERS, 2019, 卷号: 18, 期号: 1, 页码: 742-750 作者:  Mu, Xin;  Huang, Ou;  Jiang, Min;  Xie, Zuoquan;  Chen, Debo   |  收藏  |  浏览/下载：19/0  |  提交时间：2024/03/21 breast cancer  ephrin B receptors  prognosis  Kaplan-Meier plotter  hazard ratio   Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1 期刊论文  OAI收割 Journal of Experimental & Clinical Cancer Research, 2019, 卷号: 38, 期号: 1 作者:  Xia Peng;  Pengcong Hou;  Yi Chen;  Yang Dai;  Yinchun Ji   |  收藏  |  浏览/下载：12/0  |  提交时间：2021/12/01 JX06 Selectively Inhibits Pyruvate Dehydrogenase Kinase PDK1 by a Covalent Cysteine Modification 期刊论文  OAI收割 CANCER RESEARCH, 2015, 卷号: 75, 期号: 22, 页码: 4923-4936 作者:  Sun, Wenyi;  Xie, Zuoquan;  Liu, Yifu;  Zhao, Dan;  Wu, Zhixiang   |  收藏  |  浏览/下载：29/0  |  提交时间：2019/01/08 Teriflunomide, an immunomodulatory drug, exerts anticancer activity in triple negative breast cancer cells 期刊论文  OAI收割 EXPERIMENTAL BIOLOGY AND MEDICINE, 2015, 卷号: 240, 期号: 4, 页码: 426-437 作者:  Huang, Ou;  Zhang, Weili;  Zhi, Qiaoming;  Xue, Xiaofeng;  Liu, Hongchun   |  收藏  |  浏览/下载：21/0  |  提交时间：2019/01/08 Triple negative breast cancer  teriflunomide  growth factor receptor  epithelial-mesenchymal transition  Src  cell cycle